Metabolic syndrome and echocardiographic left ventricular mass in blacks: The atherosclerosis risk in communities (ARIC) study

Circulation

Volumn 112, Issue 6, 2005, Pages 819-827

  Burchfiel, Cecil M ^a,b   Skelton, Thomas N ^c   Andrew, Michael E ^b,d   Garrison, Robert J ^e   Arnett, Donna K ^f   Jones, Daniel W ^c   Taylor Jr , Herman A ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e JACKSON STATE UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diabetes mellitus; Echocardiography; Hypertension; Hypertrophy; Lipids

Indexed keywords

ALCOHOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BODY HEIGHT; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EDUCATION; FEMALE; GLUCOSE INTOLERANCE; HEART LEFT VENTRICLE MASS; HEART SIZE; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RISK; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATHEROSCLEROSIS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MISSISSIPPI; ORGAN SIZE; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 23844443889     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.518498     Document Type: Article

References (70)

1. Gotzsche O, Darwish A, Gotzsche L, Hansen LP, Sorensen KE. Incipient cardiomyopathy in young insulin-dependent diabetic patients: a seven-year prospective Doppler echocardiographic study. Diabet Med. 1996;13:834-840.
2. Gutin B, Treiber F, Owens S, Mensah GA. Relations of body composition to left ventricular geometry and function in children. J Pediatr. 1998;132:1023-1027.
3. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68:85-89.
4. Danielsen R, Nordrehaug JE, Lien E, Vik-Mo H. Subclinical left ventricular abnormalities in young subjects with long-term type 1 diabetes mellitus detected by digitized M-mode echocardiography. Am J Cardiol. 1987;60:143-146.
5. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001;103:102-107.
6. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation. 2000;101:2271-2276.
7. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986: evidence for increasing population prevalence. Arch Intern Med. 1990;150:769-773.
8. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000;283:2253-2259.
9. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey. 1988-1991. Hypertension. 1995;25:305-313.
10. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
11. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African-Americans: the Atherosclerosis Risk in Communities baseline study. Diabetes Care. 1996;19:414-418.
12. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
13. Skelton T, Andrew M, Arnett D, Burchfiel C, Garrison R, Samdarshi TE, Taylor HA, Hutchinson RG. Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study. Echocardiography. 2003;20:111-120.
14. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45:602-611.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
16. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956-960.
17. NHLBI. Atherosclerosis Risk in Communities (ARIC) Study Manual 2: Cohort Component Procedures: Visit 3: Version 4.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1993.
18. NHLBI. Atherosclerosis Risk in Communities (ARIC) Study Manual 8: Lipid and Lipoprotein Determinations: Version 2.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1994.
19. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
20. Chambless LE, McMahon RP, Brown SA, Patsch W, Heiss G, Shen YL. Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992;136:1069-1081.
21. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results: experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994;118:496-500.
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
23. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421.
24. Lane PW, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics. 1982;38:613-621.
25. SAS Institute Inc. SAS Users Guide for Sratistics, Version 6. Cary, NC: SAS Institute, Inc; 1990.
26. Trevisan M, Liu J, Bahsas FB, Menotti A, for the Risk Factor and Life Expectancy Research Group. Syndrome X and mortality, a population-based study. Am J Epidemiol. 1998;148:958-966.
27. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, Cai J, Sharrett AR. Multiple metabolic syndrome is associated with lower heart rate variability: the Atherosclerosis Risk in Communities Study. Diabetes Care. 1998;21:2116-2122.
28. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Duncan BB, Heiss G. Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR: Atherosclerosis Risk in Communities. Ann Epidemiol. 1997;7:407-416.
29. Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C. for the Conference Participants. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109:433-438.
30. Shapiro LM. Echocardiographic features of impaired ventricular function in diabetes mellitus. Br Heart J. 1982;47:439-444.
31. Uusitupa M, Siitonen O, Pyorala K, Mustonen J, Voutilainen E, Hersio K, Penttila I. Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects. Diabetes Res. 1987;4:19-25.
32. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Intern Med. 1992;152:1001-1004.
33. Nielsen FS, Ali S, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Kastrup J, Parving HH. Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy. Diabet Med. 1997;14:538-546.
34. Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, Szklo M, Ward BJ. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J. 1997;133:36-43.
35. Kuperstein R, Hanly P, Niroumand M, Sasson Z. The importance of age and obesity on the relation between diabetes and left ventricular mass. J Am Coll Cardiol. 2001;37:1957-1962.
36. Hara-Nakamura N, Kohara K, Sumimoto T, Lin M, Hiwada K. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens. 1994;7:1110-1114.
37. Costa CH, Batista MC, Moises VA, Kohlmann NB, Ribeiro AB, Zanella MT. Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients. Hypertension. 1995;26:1085-1088.
38. Ohya Y, Abe I, Fujii K, Ohmori S, Onaka U, Kobayashi K, Fujishima M. Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension. 1996;27:729-734.
39. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PWF, Vasan RS. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448-454.
40. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88:1431-1436.
41. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens. 1995;13:433-438.
42. Vetta F, Cicconetti P, Ronzoni S, Rizzo V, Palleschi L, Canarile G, Lupattelli MR, Migliori M, Morelli S, Marigliano V. Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J. 1998;19:326-331.
43. Paolisso G, Galderisi M, Tagliamonte MR, de Divitis M, Galzerano D, Petrocelli A, Gualdiero P, de Divitis O, Varricchio M. Myocardial wall thickness and left ventricular geometry in hypertensives: relationship with insulin. Am J Hypertens. 1997;10:1250-1256.
44. Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S. Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab. 1998;83:4284-4288.
45. Sherif K, Barrett M, Kushner H, Falkner B. The association of left ventricular mass with cardiovascular risk factors in African American women. Am J Med Sci. 2000;320:13-17.
46. Mureddu GF, Greco R, Rosato GF, Cella A, Vaccaro O, Contaldo F, de Simone G. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity. Int J Obes Relat Metab Disord. 1998;22:363-368.
47. Rheeder P, Stolk RP, Mosterd A, Pols HA, Hofman A, Grobbee DE. Insulin resistance syndrome and left ventricular mass in an elderly population (the Rotterdam Study). Am J Cardiol. 1999;84:233-236.
48. Devereux RB, de Simone G, Palmieri V, Oberman A, Hopkins P, Kitzman DW, Rao DC, Arnett DK. Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN Study. Am J Hypertens. 2002;15:1029-1035.
49. Saba PS, Roman JM, Pini R, Spitzer M, Gauau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22:1873-1880.
50. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med. 1996;125:221-232.
51. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
52. Chapman JN, Mayet J, Chang CL, Foale RA, Thom SA, Poulter NR. Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. Am J Hypertens. 1999;12:437-442.
53. Koren MJ, Mensah GA, Blake J, Laragh JH, Devereux RB. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens. 1993;6:815-823.
54. Fox E, Taylor H, Andrew M, Han H, Mohamed E, Garrison R, Skelton T. Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Hypertension. 2004;44:55-60.
55. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, Resnick HE, Lee ET, Best LG, de Simone G. Comparison of cardiac structure and function in Am Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol. 2004;93:40-44.
56. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, Kitzman DW, Hopkins PN, Arnett DK, Devereux RB. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN Study. J Hypertens. 2002;20:323-331.
57. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk in Communities Study. Diabetes. 2002;51:3069-3076.
58. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
59. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991;266:231-236.
60. Thomas F, Benetos A, Ducimetiere P, Bean K, Guize L. Determinants of left ventricular mass in a French male population. Blood Press. 1999;8:79-84.
61. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Mean J. 2001;141:334-341.
62. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989;110:101-107.
63. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation. 1998;98:1365-1371.
64. Lloyd-Jones DM. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep. 2001;3:184-190.
65. Aronow WS, Ahn C. Association of electrocardiographic left ventricular hypertrophy with the incidence of new congestive heart failure. J Am Geriatr Soc. 1998;46:1280-1281.
66. Gardin JM, McClelland R, Kitzman D, Lima JAC, Bommer W, Klopfenstein S, Wong ND, Smith V-E, Gottdiener J. M-mode echocardiographic predictors of six- to seven- year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001;87:1051-1057.
67. Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med. 1999;340:1221-1227.
68. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 1991;18:1287-1294.
69. Paolisso G, Galzerano D, Gambardella A, Varricchio G, Saccomanno F, D'Amore A, Varricchio M, D'Onofrio F. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest. 1995;25:529-533.
70. Devereux RB, Roman JM, Liu JE, Lee ET, Wang W, Fabsitz RR, Welty TK, Howard BV. An appraisal of echocardiography as an epidemiclogical tool: the Strong Heart Study. Ann Epidemiol. 2003;13:238-244.